About FDA
Total number of samples found to be violative and forwarded for review and regulatory follow-up in the month
Dictionary: Violative samples are Class 3 samples that fail to meet established standards and policy guidelines. Violative results are forwarded to the local Compliance Branch or the responsible regulatory center for a recommendation of regulatory action.
Fiscal Year - 2012
| Time | Target | Number of Violative Samples |
|---|---|---|
| Oct 2011 | N/A | 252 |
| Nov 2011 | N/A | 320 |
| Dec 2011 | N/A | 266 |
| Jan 2012 | N/A | TBD |
| Feb 2012 | N/A | TBD |
| Mar 2012 | N/A | TBD |
| Apr 2012 | N/A | TBD |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 YTD: 838
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
